Author: Abigail L. Coughtrie; Denise E. Morris; Rebecca Anderson; Nelupha Begum; David W. Cleary; Saul N. Faust; Johanna M. Jefferies; Alex R. Kraaijeveld; Michael V. Moore; Mark A. Mullee; Paul J. Roderick; Andrew Tuck; Robert N. Whittaker; Ho Ming Yuen; C. Patrick Doncaster; Stuart C. Clarke
Title: Epidemiological and ecological modelling reveal diversity in upper respiratory tract microbial population structures from a cross-sectional community swabbing study Document date: 2017_1_9
ID: ahdz5078_34
Snippet: Understanding the prevalence and community distribution of bacterial and viral pathogens, particularly where carriage is a prerequisite for progression to disease, is a key undertaking in the on-going development of interventional responses to changing epidemiology. Here we set out to determine the distribution of pathobiont bacterial and viral species commonly associated with respiratory tract infections using culture-independent approaches and .....
Document: Understanding the prevalence and community distribution of bacterial and viral pathogens, particularly where carriage is a prerequisite for progression to disease, is a key undertaking in the on-going development of interventional responses to changing epidemiology. Here we set out to determine the distribution of pathobiont bacterial and viral species commonly associated with respiratory tract infections using culture-independent approaches and ecological models of community assemblage as well as co-occurrence. Using multivariate analysis of microbial prevalence, we demonstrated that age affects carriage for a number of The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/099069 doi: bioRxiv preprint this set of isolates, which is indicative of the effectiveness of current PCV-13 and Hib vaccines in targeting specific serotypes as well as the effect of herd immunity in protecting individuals within age groups unlikely to have received these vaccines (41, 42) . The high proportion of non-vaccine type (NVT) S. pneumoniae reflects the process of serotype replacement as a result of vaccination, although it is not thought to lead to future large increases in the incidence of invasive disease caused by NVTs (43) . The identification of increasingly common NVT serotypes 6C, 11A/D and 23B and non-typeable H. influenzae provides important information for the epidemiological assessment of vaccines and for the development of future vaccines.
Search related documents:
Co phrase search for related documents- age group and community prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- age group and current effectiveness: 1, 2, 3
- age group and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
- age group and ecological model: 1, 2, 3
- age group and future vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9
- age group and future vaccine development: 1, 2
- age group and herd immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- age group and high proportion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
- age group and important information: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- age group and invasive disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- age group and large increase: 1, 2, 3, 4
- age group and multivariate analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- age group and non typeable influenzae: 1, 2
- age group and specific serotype: 1, 2, 3
- age group and tract infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46
- age group and vaccination result: 1, 2
- age group and viral bacterial pathogen: 1
- age group individual and community prevalence: 1
- age group individual and high proportion: 1
Co phrase search for related documents, hyperlinks ordered by date